Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03870477 · ClinicalTrials.gov registry record · NA
THP Hip Fracture Plating System Study
A NA study, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03870477: Clinical Trial NA study, sponsored by Zimmer Biomet.
NCT03870477 is a NA study that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03870477, a NA study, was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The objective of this study is to systematically document the clinical outcomes of THP Hip Fracture Plating System when used to treat intracapsular and intertrochanteric fractures.
Primary Outcome
Revision rate due to device related complication(s) or non-union of the femur.
Interventions
- DEVICE THP Hip Fracture Plating System with telescoping lag screws
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-01-16 |
| Est. Completion | 2021-03-10 |
| Phase | NA |
Why NCT03870477 stopped before completion
NCT03870477 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which THP Hip Fracture Plating System with telescoping lag screws is the first listed.
NCT03870477 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03870477 about?
NCT03870477 is a clinical study titled "THP Hip Fracture Plating System Study". The objective of this study is to systematically document the clinical outcomes of THP Hip Fracture Plating System when used to treat intracapsular and intertrochanteric fractures.
What is the current status of trial NCT03870477?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-01-16. Estimated completion is 2021-03-10.
What interventions are being tested in trial NCT03870477?
The interventions under investigation include: THP Hip Fracture Plating System with telescoping lag screws (DEVICE).
Who is sponsoring clinical trial NCT03870477?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03870477's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI